NEW YORK (TheStreet) -- Shares of Kimberly-Clark (KMB) - Get Report  are down 1.86% to $132.08 on Monday despite the company posting better-than-expected fiscal 2016 second quarter results before today's opening bell.

The Irving, TX-based personal care product company reported adjusted earnings per share of $1.53 on revenue of $4.6 billion. Analysts surveyed by Thomson Reuters expected the company to post earnings of $1.48 per share on revenue of $4.56 billion.

Kimberly-Clark forecast 2016 earnings between $5.95 and $6.15, compared to analyst yearly estimates of $6.09.

The company added that its restructuring plan, which was initiated to offset costs from the spin-off of Kimberly-Clark's health care business, is expected to be complete by the end of 2016.

Kimberly-Clark's personal care and K-C Professional divisions saw a decrease in sales year-over-year, while its consumer tissue sales remained even year-over-year. 

Separately, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author. TheStreet Ratings has this to say about the recommendation:

We rate KIMBERLY-CLARK CORP as a Buy with a ratings score of B. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations, expanding profit margins, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

You can view the full analysis from the report here: KMB

Image placeholder title

KMB

data by

YCharts